Drug Approval | June 12, 2022
Strides receives USFDA approval for Ibuprofen OTC oral suspension
Strides was granted a Competitive Generic Therapy (CGT) designation for its ANDA.
Strides was granted a Competitive Generic Therapy (CGT) designation for its ANDA.
TAK-003 is currently undergoing regulatory review for potential licensure in both the European Union
Based on a post hoc analysis, fewer required respiratory interventions
he approved product has an estimated market size of US$ 83 million for the twelve months ending April 2022, according to IQVIA.
Scemblix (asciminib) continues to show superior efficacy with more-than-two-fold improvement in major molecular response rate vs. Bosulif (bosutinib) at 96 weeks
Cloud-native Alissa data analysis SaaS platform empowers clinical labs and researchers to scale operations with parallel analysis of genomic data
The DMF#36513 demonstrates ANP’s success in the development of its “Plug and Play” drug delivery platform.
PharmaLytica Expo to aid in chalking out pharma industry’s $130 Billion growth story by 2030
The refocused commercial set-up will increase organizational efficiency and alignment across all commercial functions globally
Norliqva was approved by the FDA on February 24, 2022 and is now available through normal retail distribution.
Subscribe To Our Newsletter & Stay Updated
